Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Award for a Pioneer of Alzheimer’s Research

04.08.2015

British neuroscientist John Hardy will be awarded this year’s “Hartwig Piepenbrock-DZNE Prize” which is endowed with 60,000 Euro. Piepenbrock and the German Center for Neurodegenerative Diseases (DZNE) herewith honor his seminal contributions to the study of Alzheimer’s disease. The Professor of Neuroscience at University College London (UCL) has made groundbreaking findings on the molecular causes of this brain disorder. His discoveries provide the basis for therapeutic approaches and potential medicines. The award ceremony will take place on World Alzheimer’s Day - September 21, 2015 - in Bonn, Germany.

“John Hardy is a pioneer,“ says Prof. Pierluigi Nicotera, Chairman of the DZNE’s Executive Board. “To him we owe groundbreaking insights into the genetic causes of Alzheimer’s disease and the role of certain proteins for its pathogenesis. Hardy has been involved for more than 25 years in the investigation of Alzheimer’s and shapes this area of research to date. Worldwide, he is one of the most cited Alzheimer’s researchers by scientific journals.”

Arnulf and Olaf Piepenbrock, both Chief Executive Officers and Chairmen of Piepenbrock Group, see in the disease not only a challenge for science but also for society. “In Germany, about 1.5 Million people have dementia. Many of them are affected by Alzheimer’s. We require new approaches in order to help patients and their relatives,” as Olaf Piepenbrock explains the motif for donating the prize money. “Groundbreaking research for possible therapies is the best way to achieve this. With the award we aim at honoring outstanding accomplishments in this field.”

Every two years the “Hartwig Piepenbrock-DZNE Prize” honors outstanding contributions to the study of neurodegenerative diseases. These diseases, which include Alzheimer’s, are characterized by neuronal dysfunctions and the death of nerve cells. The prize is endowed by the Piepenbrock Group. The winner is chosen by an international committee under the coordination of the DZNE.

This year, the prize will be awarded for the third time. In 2013 it went jointly to the Swiss Adriano Aguzzi and the US-American Charles Weissmann, in 2011 the awardee was the German molecular biologist Konrad Beyreuther.

Background on the awardee

John Hardy (born 1954) is Professor of Neuroscience at University College London (UCL) and a Fellow of the Royal Society. He specializes in molecular genetics. Hardy is one of the world’s leading experts on the genetic causes of Alzheimer’s, Parkinson’s and other diseases of the nervous system. For roughly two decades, the British scientist has been giving new momentum to this field of research time and again and continues to do so today. Particularly outstanding is a discovery Hardy made at the beginning of the 1990s: He was the first to find a genetic defect that can trigger Alzheimer’s disease. Today, several such defects are known.

With the discovery of this genetic fault which may occur in the blueprint of the so-called amyloid precursor protein, Hardy laid one of the cornerstones of the “amyloid hypothesis”. This hypothesis assumes that Alzheimer’s is caused by defective proteins – called “amyloids” – that accumulate in the brain thereby damaging the nerve cells.

The amyloid hypothesis is one of the most significant models for explaining the molecular processes underlying Alzheimer’s disease. Moreover, it is the basis for several treatment approaches that aim to prevent an accumulation of defective proteins or to dissolve existing aggregates.

Further Reading
http://www.ucl.ac.uk/rlweston-inst/people/john
http://www.ucl.ac.uk/ukpdc/principal-investigators/john-hardy

The Hartwig Piepenbrock-DZNE Prize is awarded in remembrance of the Group’s former Chief Executive Officer and Chairman of the same name. Hartwig Piepenbrock himself passed away after suffering from dementia. He had been committed to art, science and society for many years.

The German Center for Neurodegenerative Diseases (DZNE) investigates the causes of diseases of the nervous system and develops strategies for prevention, treatment and care. It is an institution of the Helmholtz Association of German Research Centres with sites in Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen and Witten. The DZNE cooperates closely with universities, their clinics and other research facilities. Website: http://www.dzne.de

The Piepenbrock Group is an owner-managed family enterprise in the fourth generation. Piepenbrock relieves and strengthens its customers with a broad attendance range, for example in the business units facility management, cleaning services, maintenance and security services. In the field of mechanical engineering Piepenbrock is successful in producing packaging machines. The company is further known for its high-performance chemical products. Piepenbrock epitomizes sustainable acting. Since 2014, the company has been carrying the seal “ensured sustainability” of the “Deutsches privates Institut für Nachhaltigkeit und Ökonomie”. Website: http://www.piepenbrock.de

Weitere Informationen:

http://www.dzne.de/en/about-us/public-relations/meldungen/2015/press-release-no-...

Dr. Marcus Neitzert | idw - Informationsdienst Wissenschaft

More articles from Awards Funding:

nachricht Ultrasound Connects
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht Improving the understanding of death receptor functions in cells
07.11.2018 | Goethe-Universität Frankfurt am Main

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>